Comparison between Internal Jugular Vein versus Axilar Vein for implantable ports
Phase 3
Recruiting
- Conditions
- Malignant neoplasm, postoperative complications.C23.550.767
- Registration Number
- RBR-8p484w
- Lead Sponsor
- AC Camargo Cancer Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Minimum age 18; cancer patients; only catheter for chemotherapy; ECOG (performance status) from 0 to 2; signed informed consent form.
Exclusion Criteria
Non compliance; anticoagulant therapy; coagulopathy (platelet count below 50,000 and/or protrombin time above 18s); death within 30 days after the procedure; another catheter in superior vena cava; previous long term catheter in superior vena cava; obesity (IBM>40 Kg/m2).
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Early complications in 30 days during clinical assessment and the presence of one of the follow complications: intra-operative complications, such as pneumothorax, hemothorax, vascular injury, cardiac arrhythmia, hematoma.;Post-operative until 30 days complications identified through clinical assessment such as wound infections, catheter related bacteremia, catheter disfunction, catheter related deep venous thrombosis, reservoir extrusion and skin erosion.
- Secondary Outcome Measures
Name Time Method ate complications, the same complications used in primary outcome, but within 30 days and 6 months identified during clinical assessment.;Quality of life questionnaire to evaluate quality of life. Measured by the presence of statistically significant diference between both arms.